Global Granulocyte Macrophage Colony Stimulating Factor Market Insights, Forecast to 2025

2018-12-07 / 3900.00 / Pharma & Healthcare / 117 Pages

Description

In 2017, the global Granulocyte Macrophage Colony Stimulating Factor market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Granulocyte Macrophage Colony Stimulating Factor market based on company, product type, application and key regions.

This report studies the global market size of Granulocyte Macrophage Colony Stimulating Factor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Granulocyte Macrophage Colony Stimulating Factor in these regions.
This research report categorizes the global Granulocyte Macrophage Colony Stimulating Factor market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Granulocyte Macrophage Colony Stimulating Factor include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Granulocyte Macrophage Colony Stimulating Factor include
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd

Market Size Split by Type
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others
Market Size Split by Application
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Granulocyte Macrophage Colony Stimulating Factor market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Granulocyte Macrophage Colony Stimulating Factor market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Granulocyte Macrophage Colony Stimulating Factor manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Granulocyte Macrophage Colony Stimulating Factor with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Granulocyte Macrophage Colony Stimulating Factor submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Granulocyte Macrophage Colony Stimulating Factor are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Granulocyte Macrophage Colony Stimulating Factor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Study Coverage
1.1 Granulocyte Macrophage Colony Stimulating Factor Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Type
1.4.2 CG-0070
1.4.3 Gimsilumab
1.4.4 GSK-3196165
1.4.5 Lenzilumab
1.4.6 MGN-1601
1.4.7 Others
1.5 Market by Application
1.5.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Application
1.5.2 Solid Tumor
1.5.3 Lymphoma
1.5.4 Kidney Cancer
1.5.5 Lung Disease
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size
2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue 2016-2025
2.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales 2016-2025
2.2 Granulocyte Macrophage Colony Stimulating Factor Growth Rate by Regions
2.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Regions
2.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers
3.1.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers
3.1.2 Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers
3.1.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Concentration Ratio (CR5 and HHI)
3.2 Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers
3.2.1 Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers (2016-2018)
3.2.2 Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2016-2018)
3.3 Granulocyte Macrophage Colony Stimulating Factor Price by Manufacturers
3.4 Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base Distribution, Product Types
3.4.1 Granulocyte Macrophage Colony Stimulating Factor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Category
3.4.3 Date of International Manufacturers Enter into Granulocyte Macrophage Colony Stimulating Factor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type
4.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type
4.3 Granulocyte Macrophage Colony Stimulating Factor Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Application

6 North America
6.1 North America Granulocyte Macrophage Colony Stimulating Factor by Countries
6.1.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
6.1.2 North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Granulocyte Macrophage Colony Stimulating Factor by Type
6.3 North America Granulocyte Macrophage Colony Stimulating Factor by Application
6.4 North America Granulocyte Macrophage Colony Stimulating Factor by Company

7 Europe
7.1 Europe Granulocyte Macrophage Colony Stimulating Factor by Countries
7.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
7.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Granulocyte Macrophage Colony Stimulating Factor by Type
7.3 Europe Granulocyte Macrophage Colony Stimulating Factor by Application
7.4 Europe Granulocyte Macrophage Colony Stimulating Factor by Company

8 Asia Pacific
8.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor by Countries
8.1.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
8.1.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor by Type
8.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor by Application
8.4 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor by Company

9 Central & South America
9.1 Central & South America Granulocyte Macrophage Colony Stimulating Factor by Countries
9.1.1 Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
9.1.2 Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Granulocyte Macrophage Colony Stimulating Factor by Type
9.3 Central & South America Granulocyte Macrophage Colony Stimulating Factor by Application
9.4 Central & South America Granulocyte Macrophage Colony Stimulating Factor by Company

10 Middle East and Africa
10.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor by Countries
10.1.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
10.1.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor by Type
10.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor by Application
10.4 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor by Company

11 Company Profiles
11.1 Aduro BioTech Inc
11.1.1 Aduro BioTech Inc Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Granulocyte Macrophage Colony Stimulating Factor
11.1.4 Granulocyte Macrophage Colony Stimulating Factor Product Description
11.1.5 Recent Development
11.2 Amgen Inc
11.2.1 Amgen Inc Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Granulocyte Macrophage Colony Stimulating Factor
11.2.4 Granulocyte Macrophage Colony Stimulating Factor Product Description
11.2.5 Recent Development
11.3 BriaCell Therapeutics Corp
11.3.1 BriaCell Therapeutics Corp Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Granulocyte Macrophage Colony Stimulating Factor
11.3.4 Granulocyte Macrophage Colony Stimulating Factor Product Description
11.3.5 Recent Development
11.4 Cold Genesys Inc
11.4.1 Cold Genesys Inc Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Granulocyte Macrophage Colony Stimulating Factor
11.4.4 Granulocyte Macrophage Colony Stimulating Factor Product Description
11.4.5 Recent Development
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Granulocyte Macrophage Colony Stimulating Factor
11.5.4 Granulocyte Macrophage Colony Stimulating Factor Product Description
11.5.5 Recent Development
11.6 Humanigen Inc
11.6.1 Humanigen Inc Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Granulocyte Macrophage Colony Stimulating Factor
11.6.4 Granulocyte Macrophage Colony Stimulating Factor Product Description
11.6.5 Recent Development
11.7 Mologen AG
11.7.1 Mologen AG Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Granulocyte Macrophage Colony Stimulating Factor
11.7.4 Granulocyte Macrophage Colony Stimulating Factor Product Description
11.7.5 Recent Development
11.8 Morphotek Inc
11.8.1 Morphotek Inc Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Granulocyte Macrophage Colony Stimulating Factor
11.8.4 Granulocyte Macrophage Colony Stimulating Factor Product Description
11.8.5 Recent Development
11.9 Sillajen Biotherapeutics
11.9.1 Sillajen Biotherapeutics Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Granulocyte Macrophage Colony Stimulating Factor
11.9.4 Granulocyte Macrophage Colony Stimulating Factor Product Description
11.9.5 Recent Development
11.10 Takeda Pharmaceutical Co Ltd
11.10.1 Takeda Pharmaceutical Co Ltd Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Granulocyte Macrophage Colony Stimulating Factor
11.10.4 Granulocyte Macrophage Colony Stimulating Factor Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Granulocyte Macrophage Colony Stimulating Factor Raw Material
13.1.2 Granulocyte Macrophage Colony Stimulating Factor Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Picture of Granulocyte Macrophage Colony Stimulating Factor
Figure Global Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Production Market Share by Types (Product Category) in 2017
Figure CG-0070 Product Picture
Table Major Manufacturers of CG-0070
Figure Gimsilumab Product Picture
Table Major Manufacturers of Gimsilumab
Figure GSK-3196165 Product Picture
Table Major Manufacturers of GSK-3196165
Figure Lenzilumab Product Picture
Table Major Manufacturers of Lenzilumab
Figure MGN-1601 Product Picture
Table Major Manufacturers of MGN-1601
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Application 2018-2025 (K Pcs)
Figure Solid Tumor
Figure Lymphoma
Figure Kidney Cancer
Figure Lung Disease
Figure Others
Figure Granulocyte Macrophage Colony Stimulating Factor Report Years Considered
Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size 2016-2025 (Million US$)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales 2016-2025 (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Regions 2016-2025 (K Pcs) & (Million US$)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales by Regions 2016-2025 (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Regions 2016-2025
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Regions 2016-2025
Figure 2017 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Regions
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions 2016-2025 (Million US$)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions 2016-2025
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions 2016-2025
Figure 2017 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers (2016-2018) (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Manufacturers (2016-2018)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Manufacturers in 2017
Table Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers (2016-2018) (Million US$)
Table Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2016-2018)
Figure Granulocyte Macrophage Colony Stimulating Factor Value Share by Manufacturers in 2017
Table Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Price (2016-2018) (USD/Pcs)
Table Granulocyte Macrophage Colony Stimulating Factor Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Category
Table Date of International Manufacturers Enter into Granulocyte Macrophage Colony Stimulating Factor Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2025) (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Type (2016-2025)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2016-2025)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type in 2017
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2016-2025) (Million US$)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Type (2016-2025)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2016-2025)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type in 2017
Table Granulocyte Macrophage Colony Stimulating Factor Price by Type 2013-2018 (USD/Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2025) (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Application (2016-2025)
Figure Global Sales Granulocyte Macrophage Colony Stimulating Factor Market Share by Application (2016-2025)
Figure Global Sales Granulocyte Macrophage Colony Stimulating Factor Market Share by Application (2016-2025)
Figure North America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2016-2025 (K Pcs)
Figure North America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2016-2025 (Million US$)
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2016-2025) (K Pcs)
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2016-2025)
Figure 2017 North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries
Table North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2016-2025) (Million US$)
Table North America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries
Figure United States Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure United States Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Canada Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Mexico Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2025) (K Pcs)
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2016-2025)
Figure 2017 North America Granulocyte Macrophage Colony Stimulating Factor Market Share by Type
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2025) (K Pcs)
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2016-2025)
Figure 2017 North America Granulocyte Macrophage Colony Stimulating Factor Market Share by Application
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales by Company (2016-2018) (K Pcs)
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company (2016-2018)
Figure North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company in 2017
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2016-2025 (K Pcs)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2016-2025) (K Pcs)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries
Table Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2016-2025) (Million US$)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries
Figure Germany Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Germany Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (K Pcs)
Figure France Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure France Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (K Pcs)
Figure UK Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure UK Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Italy Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Russia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2025) (K Pcs)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2016-2025)
Figure 2017 Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by Type
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2025) (K Pcs)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2016-2025)
Figure 2017 Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by Application
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Company (2016-2018) (K Pcs)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company (2016-2018)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company in 2017
Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2016-2025 (K Pcs)
Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2016-2025) (K Pcs)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries
Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure China Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Korea Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure India Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure India Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Australia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Indonesia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Malaysia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Philippines Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Thailand Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Vietnam Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Singapore Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2025) (K Pcs)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Share by Type
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2025) (K Pcs)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Share by Application
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Company (2016-2018) (K Pcs)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company (2016-2018)
Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company in 2017
Figure Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2016-2025 (K Pcs)
Figure Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2016-2025) (K Pcs)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries
Figure Brazil Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Brazil Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Argentina Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2025) (K Pcs)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Granulocyte Macrophage Colony Stimulating Factor Market Share by Type
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2025) (K Pcs)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Granulocyte Macrophage Colony Stimulating Factor Market Share by Application
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales by Company (2016-2018) (K Pcs)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company (2016-2018)
Figure Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company in 2017
Figure Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2016-2025 (K Pcs)
Figure Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2016-2025) (K Pcs)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries
Figure GCC Countries Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure GCC Countries Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Turkey Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure Egypt Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2016-2025) (K Pcs)
Figure South Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2025) (K Pcs)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Share by Type
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2025) (K Pcs)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Share by Application
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Company (2016-2018) (K Pcs)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company in 2017
Table Aduro BioTech Inc Company Details
Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Aduro BioTech Inc Recent Development
Table Amgen Inc Company Details
Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Amgen Inc Recent Development
Table BriaCell Therapeutics Corp Company Details
Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table BriaCell Therapeutics Corp Recent Development
Table Cold Genesys Inc Company Details
Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Cold Genesys Inc Recent Development
Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table GlaxoSmithKline Plc Recent Development
Table Humanigen Inc Company Details
Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Humanigen Inc Recent Development
Table Mologen AG Company Details
Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Mologen AG Recent Development
Table Morphotek Inc Company Details
Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Morphotek Inc Recent Development
Table Sillajen Biotherapeutics Company Details
Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Sillajen Biotherapeutics Recent Development
Table Takeda Pharmaceutical Co Ltd Company Details
Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Takeda Pharmaceutical Co Ltd Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Granulocyte Macrophage Colony Stimulating Factor Value Chain
Table Typical Suppliers of Key Granulocyte Macrophage Colony Stimulating Factor Raw Material
Table Granulocyte Macrophage Colony Stimulating Factor Customers List
Table Granulocyte Macrophage Colony Stimulating Factor Sales Channels
Table Granulocyte Macrophage Colony Stimulating Factor Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory